Get access

Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients

Authors

  • B. Daubail,

    1. Department of Neurology and Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon;, France
    Search for more papers by this author
  • A. Jacquin,

    1. Department of Neurology and Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon;, France
    Search for more papers by this author
  • J.-C. Guilland,

    1. Biochimie Spécialisée, Pôle Technique de Biologie, Dijon University Hospital, Dijon, France
    Search for more papers by this author
  • M. Hervieu,

    1. Department of Neurology and Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon;, France
    Search for more papers by this author
  • G.-V. Osseby,

    1. Department of Neurology and Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon;, France
    Search for more papers by this author
  • O. Rouaud,

    1. Department of Neurology and Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon;, France
    Search for more papers by this author
  • M. Giroud,

    1. Department of Neurology and Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon;, France
    Search for more papers by this author
  • Y. Béjot

    Corresponding author
    1. Department of Neurology and Dijon Stroke Registry, EA4184, University Hospital and Medical School of Dijon, University of Burgundy, Dijon;, France
    • Correspondence: Dr Y. Bejot, Department of Neurology, CHU Dijon, 3 Rue du Faubourg Raines, 21000 Dijon, France (tel.: +33 (0)380293753; fax: +33 (0)380293672; e-mail: ybejot@yahoo.fr).

    Search for more papers by this author

  • See editorial by Michos and Gottesman on page 3.

Abstract

Background and purpose

We aimed to evaluate the association between 25-hydroxyvitamin D (25(OH)D) levels and both clinical severity at admission and outcome at discharge in stroke patients.

Methods

From February 2010 to December 2010, consecutive stroke patients admitted to the Department of Neurology of Dijon, France, were identified. Clinical information was collected. Serum concentration of 25(OH)D was measured at baseline. Stroke severity was assessed at admission using the NIHSS score. Functional impairment was evaluated at discharge using the modified Rankin scale (m-Rankin). Multivariate analyses were performed using logistic regression models.

Results

Of the 386 recorded patients, serum 25(OH)D levels were obtained in 382 (median value = 35.1 nM; IQR = 21–57.8). At admission, 208 patients had a NIHSS ≤5, with a higher mean 25(OH)D level than that observed in patients with moderate-to-high severity (45.9 vs. 38.6 nM, P < 0.001). In multivariate analyses, a 25(OH)D level in the lowest tertile (<25.7 nM) was a predictor of a NIHSS ≥6 (OR = 1.67; 95% CI = 1.05–2.68; P = 0.03). The mean 25(OH)D level was lower in patients with moderate-to-severe handicap at discharge (m-Rankin 3–6) than in patients with no or mild handicap (35.0 vs. 47.5 nM, P < 0.001). In multivariate analyses, the lowest tertile of 25(OH)D level (<25.7 nM) was associated with a higher risk of moderate-to-severe handicap (OR = 2.06; 95% CI = 1.06–3.94; P = 0.03).

Conclusion

A low serum 25(OH)D level is a predictor of both severity at admission and poor early functional outcome in stroke patients. The underlying mechanisms of these associations remain to be investigated.

Ancillary